Duchemin brings global MedTech leadership experience to accelerate Fotona's next phase of growth

DALLAS , May 15, 2025 /PRNewswire/ -- Fotona^Ⓡ, a global leader in high-performing laser systems and energy-based devices for aesthetic, dental and gynecological applications, today announces the appointment of Jeff Duchemin as Group President and CEO.

Duchemin brings decades of leadership experience in the global medical technology sector, having held senior roles in both U.S. and international markets. Most recently, he served in executive roles in the Interventional Surgery and Integrated Diagnostic Solutions business at Becton Dickinson along with being the former President and CEO of Harvard Biosciences. His expertise in driving revenue growth--both organically and through strategic acquisitions--will play a critical role in advancing Fotona's innovation and expanding its presence globally. Duchemin holds an M.B.A from Southern New Hampshire University and a B.S. in Accounting from the University of Massachusetts Dartmouth.

"Jeff is a visionary leader with a strong track record of driving global success in the life sciences and medical device industries," said Jay Katzen, Executive Chairman, Fotona. "We are excited to have him join Fotona, which has industry leading experts and solutions, to lead Fotona through its next chapter of innovation and market leadership."

"Innovation is at the heart of Fotona," said Duchemin. "I'm passionate about accelerating growth by enhancing our current solutions and introducing breakthrough technologies. Fotona has a solid foundation, exceptional talent, and world-class products. It's an honor to lead the company at such a pivotal time in its journey."

Last year, Fotona proudly marked 60 years of innovation in laser technology. Throughout its history, the company has been at the forefront of industry advancements, including the groundbreaking integration of dual laser wavelengths (Er:YAG and Nd:YAG) within a single system. Most recently, Fotona launched the Dynamis® Max, its next-generation aesthetic platform offering expanded versatility, improved usability, and enhanced treatment efficiency--supporting more than 100 advanced treatment applications.

For more information, visit Fotona.com.

About Fotona

Fotona is a world-leading medical laser company recognized for its innovative, award-winning laser systems for applications in aesthetics & dermatology, dentistry, surgery and gynecology. The company has one of the most highly educated workforces in the industry, with an exceptionally high number of PhDs specializing in laser and medical technology innovation. In addition to its direct presence in the US, China, Japan and the EU, Fotona's global distribution network spans across more than 70 countries, ensuring comprehensive support and service for Fotona laser users, including clinical training. www.fotona.com.

View original content:https://www.prnewswire.co.uk/news-releases/fotona-appoints-jeff-duchemin-as-group-president-and-ceo-302456335.html

Tags

More Like This

Fotona Appoints Miha Debelak as Vice President, EMEA General Manager to Accelerate Regional Growth

ViaLase Announces Strategic Leadership Transitions to Support Commercial Growth

Filippo Fagnani from Quanta System Receives the EAU Award for Significant Contribution to Endourology at ICE 2026

DEKA Plays Its Poker Quad With Four New Laser Platforms at IMCAS Paris, the World Dermatology and Plastic and Aesthetic Surgery Congress

Caron Scientific Announces Leadership Transitions

/C O R R E C T I O N -- Suanfarma/

FarmaMondo Group appoints Independent Board Director Natalie Douglas, global pharmaceutical managed access and commercialization pioneer

Envision Pharma Group Strengthens Executive Leadership Team to Accelerate Growth, Innovation and Global Client Delivery